Euda Health Holdings Limited (EUDA) — Titan Protect Analysis

EUDA

Euda Health Holdings Limited

Real Estate · ·

$16.06

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$51M

Total market value of the company

Trailing P/E

N/A

Forward P/E

10.63

Based on estimated future earnings — lower means cheaper

Rev Growth

+78.9%

Year-over-year revenue change

Profit Margin

-40.7%

How much profit the company keeps from each dollar of revenue

ROE

N/A

Return on equity — how efficiently it uses shareholder money

Analyst Target

$55.00

+242% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 1 analysts covering this stock

About Euda Health Holdings Limited

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.

https://eudahealth.com

Country: Singapore Employees: 123 Industry: Real Estate Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.277

Positive but modest risk-adjusted returns

Kelly Fraction

0.0127

Marginal edge — very small allocation suggested

Calmar Ratio

-0.449

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-43.0%

Historical annualised return based on price data

Max Drawdown

-95.7%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.56

Less volatile than the market — more defensive

52W High

$86.00

81% below the year high

52W Low

$5.26

205% above the year low

Avg Volume

118,176

Average daily shares traded — higher means easier to buy and sell

Short Ratio

0.1

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-1.48

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

N/A

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

43.9%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-34.8%

Profit from core operations before interest and tax

Free Cash Flow

$-953,881

Negative — the business is spending more than it generates

Revenue (TTM)

$7M

Total revenue over the last 12 months

Net Income

$-2,772,762

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$55.00

Target Median

$55.00

Target Low

$55.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go